Tag Archives: Accuraseed

Fujifilm Avigan Phase III Clinical Trial Update

Regarding the end of enrollment of subjects in the Japanese clinical phase III study for patients with the new coronavirus infection, the anti-influenza virus drug “Avigan ® Tablets” FUJIFILM Toyama Chemical Co., Ltd. (Headquarters: Chuo-ku, Tokyo / President: Junji Okada, hereafter FUJIFILM Toyama Chemical) has announced the anti-influenza virus drug “Avigan ® Tablets” (generic name: […]

Posted in Press releases | Also tagged , , , , , , , , | Leave a comment

Fujifilm New Coronavirus Antigen Quantitative Test Reagent

Immunoanalyzer “Accuraseed” that enables rapid measurement®” exclusive New Coronavirus Antigen Quantitative Test Reagent “Acura Seed SARS‐CoV‐2 Antigen”(In‐vitro diagnostic drug) Fujifilm Wako Junyaku Co., Ltd. (Headquarters: Chuo‐ku, Osaka City, President: Kazuo Shiraki) has developed a new type of coronavirus (accuraseed) as a dedicated reagent for the automatic chemiluminescent enzyme immunoassay device Accuraseed, which enables rapid measurement. […]

Posted in Press releases | Also tagged , , , , , , , , | Leave a comment